Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;40(1):1-9.
doi: 10.1016/j.jgyn.2010.11.007. Epub 2010 Dec 23.

[Termination of pregnancy and intra-uterine fetal death after 14 weeks of pregnancy: Which protocol for induction of labour in 2010?]

[Article in French]
L Gitz  1 , O Morel, O Thiebaugeorges, J Sibiude, P Desfeux, E Barranger
Affiliations
Free article
Review

[Termination of pregnancy and intra-uterine fetal death after 14 weeks of pregnancy: Which protocol for induction of labour in 2010?]

[Article in French]
L Gitz et al. J Gynecol Obstet Biol Reprod (Paris). 2011 Feb.
Free article

Abstract

The induction of labour for intra-uterine fetal death (IUFD) and termination of pregnancy (TOP) is a common obstetrical situation. The management of these specific inductions has improved.

Objectives: Define a protocol that meets the several constraints of security, efficiency and cost for labor induction for IUFD and TOP.

Materials and methods: Review.

Results: The protocol chosen uses the mifepristone 200mg by oral way on the first day for cervical preparation, completed by placing laminaria tents the evening of the 2nd day if the membranes are unreachable. On the 3rd day, in the birth room, the labor starts under analgesia, by using misoprostol 400 μg through vaginal way every 3 hours. Specific situations such as scarred uterus need modifications.

Conclusion: Many protocols are described in the literature, they differ in their molecules, their dosages and their associations. This review offers a protocol that meets the announced objectives.

PubMed Disclaimer